The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding
Abstract
Clinical observations support a central role of the dopamine system in restless legs syndrome (RLS) but previous imaging studies of striatal dopamine D2-receptors have yielded inconclusive results. Extrastriatal dopaminergic function has hitherto not been investigated. Sixteen RLS patients naïve to dopaminergic drugs and sixteen matched control subjects were examined with PET. [11C]Raclopride and [11C]FLB 457 were used to estimate D2-receptor availability in striatum and extrastriatal regions, respectively. Examinations were performed both in the morning (starting between 10:00 and 12:00 h) and evening (starting at 18:00 h). Measures were taken to monitor and control for head movement during data acquisition. In the striatum, patients had significantly higher [11C]raclopride binding potential (BP) values than controls. In extrastriatal regions, [11C]FLB 457 BP was higher in patients than controls, and in the regional analysis the difference was statistically significant in subregions of thalamus and the anterior cingulate cortex. The diurnal variability in BP with [11C]FLB 457 and [11C]raclopride was within the previously reported test-retest reproducibility for both radioligands. The study supports involvement of the dopamine system in both striatal and extrastriatal brain regions in the pathophysiology of RLS. The brain regions where differences in D2-receptor binding were shown are implicated in the regulation of affective and motivational aspects of sensory processing, suggesting a possible pathway for sensory symptoms in RLS. Increased D2-receptor availability in RLS may correspond to higher receptor densities or lower levels of endogenous dopamine. Both interpretations are consistent with the hypothesis of hypoactive dopaminergic neurotransmission in RLS, as increased receptor levels can be owing to receptor upregulation in response to low levels of endogenous dopamine. The results do not support variations in dopamine D2-receptor availability as a correlate to the diurnal rhythm of RLS symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multimodality image registration by maximization of mutual information
Maes, F., Collignon, A., Vandermeulen, D., Marchal, G., & Suetens, P. (1997) · IEEE Transactions on Medical Imaging · doi:10.1109/42.563664 · Cited by 4,547
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology
Allen, R. P., Picchietti, D., Hening, W. A., Trenkwalder, C., Walters, A. S., & Montplaisi, J. (2003) · Sleep Medicine · doi:10.1016/s1389-9457(03)00010-8 · Cited by 2,900
Pain Affect Encoded in Human Anterior Cingulate But Not Somatosensory Cortex
Rainville, P., Duncan, G. H., Price, D. D., Carrier, B., & Bushnell, M. C. (1997) · Science · doi:10.1126/science.277.5328.968 · Cited by 2,687
A Rating Scale for Drug-Induced Akathisia
Barnes, T. R. E. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.5.672 · Cited by 2,170
Psychological and neural mechanisms of the affective dimension of pain
Price, D. D. (2000) · Science · doi:10.1126/science.288.5472.1769 · Cited by 2,092
Simplified Reference Tissue Model for PET Receptor Studies
Lammertsma, A. A., & Hume, S. P. (1996) · NeuroImage · doi:10.1006/nimg.1996.0066 · Cited by 2,021
(2003) · Sleep Medicine · doi:10.1016/s1389-9457(02)00258-7 · Cited by 1,682
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G.-J., Ding, Y.-S., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,514
Restless Legs Syndrome Prevalence and Impact: REST General Population Study
Allen, R. P., Walters, A. S., Montplaisir, J., Hening, W., Myers, A., Bell, T. J., & Ferini-Strambi, L. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.11.1286 · Cited by 1,182
Mintun, M. A., Raichle, M. E., Kilbourn, M. R., Wooten, G. F., & Welch, M. J. (1984) · Annals of Neurology · doi:10.1002/ana.410150302 · Cited by 955
Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944
Jönsson, E. G., Nöthen, M. M., Grünhage, F., Farde, L., Nakashima, Y., Propping, P., & Sedvall, G. C. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000532 · Cited by 721
Joel, D., & Weiner, I. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00575-8 · Cited by 614 · cited 1×
“…ROIs were defined according to a method described in the literature (Mawlawi et al., 2001; Martinez et al., 2003) in which striatum is divided into limbic (LST), associative (AST) and sensorimotor (SMST) subregions based on the differential connectivity of the striatum (Joel and Weiner, 2000).”
MethodMartinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048520.34839.1a · Cited by 569
The ECAT EXACT HR: Performance of a New High Resolution Positron Scanner
Wienhard, K., Dahlbom, M., Eriksson, L., Michel, C., Bruckbauer, T., Pietrzyk, U., & Heiss, W.-D. (1994) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199401000-00023 · Cited by 561
Mawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525 · cited 3×
“…the average change between exam- inations performed in the morning and evening during the same day was within the previously reported test–retest reproducibility for both radioligands (Hietala et al., 1999; Vilkman et al., 2000; Mawlawi et al., 2001; Sudo et al., 2001; Hirvonen et al., 2003).”
MethodResultStriatal dopaminergic function in restless legs syndrome: 18F-dopa and11C-raclopride PET studies
Turjanski, N., Lees, A. J., & Brooks, D. J. (1999) · Neurology · doi:10.1212/wnl.52.5.932 · Cited by 416
Ballmaier, M., Toga, A. W., Blanton, R. E., Sowell, E. R., Lavretsky, H., Peterson, J., Pham, D., & Kumar, A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.99 · Cited by 384
Winkelmann, J., Wetter, T. C., Collado-Seidel, V., Gasser, T., Dichgans, M., Yassouridis, A., & Trenkwalder, C. (2000) · Sleep · doi:10.1093/sleep/23.5.1b · Cited by 363
Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain
Kaasinen, V (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00149-4 · Cited by 352
PET and MRI of the thalamus in never-medicated patients with schizophrenia
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.2.191 · Cited by 324
Epidemiology of restless legs syndrome in French adults: A nationwide survey: The INSTANT Study
Tison, F., Crochard, A., Léger, D., Bouée, S., Lainey, E., & El Hasnaoui, A. (2005) · Neurology · doi:10.1212/01.wnl.0000168910.48309.4a · Cited by 323
Bergstr??m, M., Bo??thius, J., Eriksson, L., Greitz, T., Ribbe, T., & Wid??n, L. (1981) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198102000-00027 · Cited by 315
Reserpine and Gastric Secretion in Man
KROGSGAARD, A. R. (1957) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1957.tb15737.x · Cited by 313
An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome
Ruottinen, H. M., Partinen, M., Hublin, C., Bergman, J., Haaparanta, M., Solin, O., & Rinne, J. O. (2000) · Neurology · doi:10.1212/wnl.54.2.502 · Cited by 281
Michaud, M., Soucy, J.-P., Chabli, A., Lavigne, G., & Montplaisir, J. (2002) · Journal of Neurology · doi:10.1007/pl00007859 · Cited by 278
Circadian Rhythm of Motor Restlessness and Sensory Symptoms in the Idiopathic Restless Legs Syndrome
Hening, W., Walters, A., Wagner, M., PharmD, Rosen, R., Chen, V., Kim, S., Shah, M., & Thai, O. (1999) · Sleep · doi:10.1093/sleep/22.7.901 · Cited by 276
Striatal dopamine D1 and D2 receptors in burning mouth syndrome
Hagelberg, N., Forssell, H., Rinne, J. O., Scheinin, H., Taiminen, T., Aalto, S., Luutonen, S., Någren, K., & Jääskeläinen, S. (2003) · Pain · doi:10.1016/s0304-3959(02)00323-8 · Cited by 264
Winkelmann, J., Muller‐Myhsok, B., Wittchen, H., Hock, B., Prager, M., Pfister, H., Strohle, A., Eisensehr, I., Dichgans, M., Gasser, T., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10282 · Cited by 255
Human brain atlas: For high‐resolution functional and anatomical mapping
Roland, P. E., Graufelds, C. J., Wǎhlin, J., Ingelman, L., Andersson, M., Ledberg, A., Pedersen, J., Åkerman, S., Dabringhaus, A., & Zilles, K. (1994) · Human Brain Mapping · doi:10.1002/hbm.460010303 · Cited by 252
Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome
Trenkwalder, C., Hening, W. A., Walters, A. S., Campbell, S. S., Rahman, K., & Chokroverty, S. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1<102::aid-mds1017>3.0.co;2-e · Cited by 226
Thalamic Volumes in Patients With First-Episode Schizophrenia
Gilbert, A. R., Rosenberg, D. R., Harenski, K., Spencer, S., Sweeney, J. A., & Keshavan, M. S. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.4.618 · Cited by 206
Altered dopamine D2 receptor binding in atypical facial pain
Hagelberg, N., Forssell, H., Aalto, S., Rinne, J. O., Scheinin, H., Taiminen, T., Någren, K., Eskola, O., & Jääskeläinen, S. K. (2003) · Pain · doi:10.1016/s0304-3959(03)00275-6 · Cited by 205
Crespo-Facorro, B. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00028-1 · Cited by 190
Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome
Eisensehr, I., Wetter, T. C., Linke, R., Noachtar, S., Lindeiner, H. V., Gildehaus, F. J., Trenkwalder, C., & Tatsch, K. (2001) · Neurology · doi:10.1212/wnl.57.7.1307 · Cited by 184
Variability in D2‐dopamine receptor density and affinity: A PET study with [11C]raclopride in man
Farde, L., Hall, H., Pauli, S., & Halldin, C. (1995) · Synapse · doi:10.1002/syn.890200303 · Cited by 175
Quantification of [11C]FLB 457 Binding to Extrastriatal Dopamine Receptors in the Human Brain
Olsson, H., Halldin, C., Swahn, C.-G., & Farde, L. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199910000-00013 · Cited by 174
Positron emission tomographic studies in restless legs syndrome
Trenkwalder, C., Walters, A. S., Hening, W. A., Chokroverty, S., Antonini, A., DHAWAN, V. M., & Eidelberg, D. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1<141::aid-mds1024>3.0.co;2-b · Cited by 170
The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study
von Spiczak, S., Whone, A. L., Hammers, A., Asselin, M.-C., Turkheimer, F., Tings, T., Happe, S., Paulus, W., Trenkwalder, C., & Brooks, D. J. (2005) · Brain · doi:10.1093/brain/awh441 · Cited by 157
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Gatley, S. J., MacGregor, R. R., Schlyer, D. J., HITZEMANN, R. J., & Wolf, A. P. (1996) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(96)02809-0 · Cited by 154
Hagelberg, N. M., Martikainen, I. K., Mansikka, H. T., Hinkka‐Yli‐Salomäki, S., Någren, K., Hietala, J. A., Scheinin, H., & Pertovaara, A. (2002) · Pain · doi:10.1016/s0304-3959(02)00121-5 · Cited by 152
Circadian rhythm of restless legs syndrome: Relationship with biological markers
Michaud, M., Dumont, M., Selmaoui, B., Paquet, J., Fantini, M. L., & Montplaisir, J. Y. (2004) · Annals of Neurology · doi:10.1002/ana.10843 · Cited by 147
Trenkwalder, C., & Paulus, W. (2004) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.01.031 · Cited by 146
Bilateral thalamic gray matter changes in patients with restless legs syndrome
Etgen, T., Draganski, B., Ilg, C., Schröder, M., Geisler, P., Hajak, G., Eisensehr, I., Sander, D., & May, A. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.10.021 · Cited by 141
Staedt, J., Stoppe, G., Kögler, A., Riemann, H., Hajak, G., Munz, D. L., Emrich, D., & Rüther, E. (1995) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02191538 · Cited by 133
Periodic Leg Movements in Sleep and Restless Legs Syndrome Probably Caused by Olanzapine
Kraus, T., Schuld, A., & Pollmächer, T. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910000-00017 · Cited by 129
Restless Legs Syndrome Probably Induced by Risperidone Treatment
Wetter, T. C., Brunner, J., & Bronisch, T. (2002) · Pharmacopsychiatry · doi:10.1055/s-2002-31514 · Cited by 127
Low Dopamine D2Receptor Binding in Subregions of the Thalamus in Schizophrenia
Yasuno, F., Suhara, T., Okubo, Y., Sudo, Y., Inoue, M., Ichimiya, T., Takano, A., Nakayama, K., Halldin, C., & Farde, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1016 · Cited by 122
Langer, O., Någren, K., Dollé, F., Lundkvist, C., Sandell, J., Swahn, C., Vaufrey, F., Crouzel, C., Maziere, B., & Halldin, C. (1999) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/(sici)1099-1344(199912)42:12<1183::aid-jlcr274>3.0.co;2-z · Cited by 116
Distribution of Dopamine D2-Like Receptors in the Human Thalamus: Autoradiographic and PET Studies
Rieck, R. W., Ansari, M. S., Whetsell, W. O., Deutch, A. Y., & KESSLER, R. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300336 · Cited by 106
Ginovart, N., Farde, L., Halldin, C., & Swahn, C. (1997) · Synapse · Cited by 105
Olsson, H., Halldin, C., & Farde, L. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.02.002 · Cited by 99
Idiopathic restless legs syndrome: Abnormalities in central somatosensory processing
Schattschneider, J., Bode, A., Wasner, G. L., Binder, A., Deuschl, G., & Baron, R. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0475-3 · Cited by 98
Farde, L. (1992) · Psychopharmacology · doi:10.1007/bf02244961 · Cited by 86
Verhoeff, N. P. L. G., Kapur, S., Hussey, D., Lee, M., Christensen, B. K., Psych, C., Papatheodorou, G. N., & Zipursky, R. B. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00231-7 · Cited by 83
Hietala, J. A., Någren, K., Lehikoinen, P., Ruotsalainen, U., & Syvälahti, J. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199902000-00012 · Cited by 79
Cselényi, Z., Olsson, H., Halldin, C., Gulyás, B. Z., & Farde, L. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.02.053 · Cited by 77
Cerebral cortex: a topographic segmentation method using magnetic resonance imaging
Crespo‐Facorro, B., Kim, J., Andreasen, N. C., Spinks, R. A., OʼLeary, D. S., Bockholt, H. J., Harris, G., & Magnotta, V. A. (2000) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(00)00072-x · Cited by 77
Ginovart, N., Farde, L., Halldin, C., & Swahn, C.-G. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199902)31:2<154::aid-syn9>3.0.co;2-k · Cited by 76
Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride
Hirvonen, J., Aalto, S., Lumme, V., N??GREN, K., Kajander, J., Vilkman, H., Hagelberg, N. M., Oikonen, V., & Hietala, J. A. (2003) · Nuclear Medicine Communications · doi:10.1097/00006231-200312000-00002 · Cited by 74
Linke, R., Eisensehr, I., Wetter, T., Gildehaus, F., Pöpperl, G., Trenkwalder, C., Noachtar, S., & Tatsch, K. (2004) · Movement Disorders · doi:10.1002/mds.20226 · Cited by 70
μ‐Receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man
Hagelberg, N. M., Kajander, J., Någren, K., Hinkka‐Yli‐Salomäki, S., Hietala, J. A., & Scheinin, H. (2002) · Synapse · doi:10.1002/syn.10078 · Cited by 69
Cselényi, Z., Olsson, H., Farde, L., & Gulyás, B. Z. (2002) · NeuroImage · doi:10.1006/nimg.2002.1152 · Cited by 67
Martikainen, I. K., Hagelberg, N. M., Mansikka, H. T., Hietala, J. A., Någren, K., Scheinin, H., & Pertovaara, A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.045 · Cited by 66
Periodic Restless Legs Syndrome Associated With Quetiapine Use
Pinninti, N. R., Mago, R., Townsend, J., & Doghramji, K. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000186870.75042.25 · Cited by 64
Reproducibility of [11C]FLB 457 binding in extrastriatal regions
SUDO, Y., Suhara, T., Inoue, M., Ito, H., Suzuki, K., Saijo, T., Halldin, C., & Farde, L. (2001) · Nuclear Medicine Communications · doi:10.1097/00006231-200111000-00008 · Cited by 64
Modeling Dynamic PET-SPECT Studies in the Wavelet Domain
Turkheimer, F., Banati, R. B., Visvikis, D., Aston, J. A. D., Gunn, R. N., & Cunningham, V. J. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200005000-00015 · Cited by 60
Chou, Y.-H., Halldin, C., & Farde, L. (2000) · Synapse · Cited by 57
Huang, N. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00093-9 · Cited by 57
Dopamine Transmission in the Schizophrenic Brain
Laruelle, M. A. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch20 · Cited by 56
Differential Regulation of Dopamine D2 and D3 Receptors by Chronic Drug Treatments
Stanwood, G. D., Lucki, I., & McGonigle, P. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39025-1 · Cited by 50
Joyce, J. N. (2001) · Synapse · doi:10.1002/syn.1035 · Cited by 47
Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects
Hagelberg, N. M., Aalto, S., Kajander, J., Oikonen, V., Hinkka‐Yli‐Salomäki, S., Någren, K., Hietala, J. A., & Scheinin, H. (2004) · Pain · doi:10.1016/j.pain.2004.01.013 · Cited by 46
Computerized movement analysis and beta-CIT-SPECT in patients with restless legs syndrome
Mrowka, M., J�bges, M., Berding, G., Schimke, N., Shing, M., & Odin, P. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0217-9 · Cited by 38
Hurley, M. J., Stubbs, C. M., Jenner, P. G., & MARSDEN, C. D. (1996) · Psychopharmacology · doi:10.1007/s002130050146 · Cited by 28
Mathieu-Kia, A.-M., Caboche, J., & Besson, M. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199606)23:2<115::aid-syn7>3.0.co;2-c · Cited by 27
Emerging drugs for restless legs syndrome
Fulda, S., & Wetter, T. C. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.3.537 · Cited by 26
Andersson, M., Terasmaa, A., Fuxé, K., & Strömberg, I. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20630 · Cited by 20
Genetics of restless legs syndrome
Mata, I. F., Bodkin, C. L., Adler, C. H., Lin, S.-C., Uitti, R. J., Farrer, M. J., & Wszołek, Z. K. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.08.006 · Cited by 14
Bratus', V. V., Talaieva, T. V., Radalovs'ka, N. V., et al. (1999) · PubMed · Cited by 6
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1
Cited by
Role of central dopamine in pain and analgesia
Wood, P. B. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.781 · Cited by 370
Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome
Connor, J. R., Wang, X.-S., Allen, R. P., Beard, J. L., Wiesinger, J. A., Felt, B. T., & Earley, C. J. (2009) · Brain · doi:10.1093/brain/awp125 · Cited by 353
Sensory aspects of movement disorders
Patel, N., Jankovic, J., & Hallett, M. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70213-8 · Cited by 343
Restless legs syndrome: pathophysiology, clinical presentation and management
Trenkwalder, C., & Paulus, W. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.55 · Cited by 310
Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome
Paulus, W., & Trenkwalder, C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70576-2 · Cited by 181
Metadata
- Authors
- Cervenka, S.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07-01
- Volume
- 129
- Issue
- 8
- Pages
- 2017-2028
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2137282995
- Cited by
- 252
- References
- 81
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.